Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Palisade Bio (PALI) EPS (Basic) (2016 - 2025)

Palisade Bio (PALI) has disclosed EPS (Basic) for 16 consecutive years, with -$0.33 as the latest value for Q3 2025.

  • On a quarterly basis, EPS (Basic) rose 79.25% to -$0.33 in Q3 2025 year-over-year; TTM through Sep 2025 was -$2.07, a 84.4% increase, with the full-year FY2024 number at -$10.19, up 62.27% from a year prior.
  • EPS (Basic) was -$0.33 for Q3 2025 at Palisade Bio, up from -$0.58 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of $0.42 in Q3 2021 to a low of -$16.16 in Q4 2022.
  • A 5-year average of -$4.53 and a median of -$3.68 in 2021 define the central range for EPS (Basic).
  • Biggest YoY gain for EPS (Basic) was 423.08% in 2021; the steepest drop was 2293.33% in 2021.
  • Palisade Bio's EPS (Basic) stood at $0.42 in 2021, then tumbled by 3947.62% to -$16.16 in 2022, then surged by 76.67% to -$3.77 in 2023, then soared by 81.7% to -$0.69 in 2024, then skyrocketed by 52.17% to -$0.33 in 2025.
  • Per Business Quant, the three most recent readings for PALI's EPS (Basic) are -$0.33 (Q3 2025), -$0.58 (Q2 2025), and -$0.47 (Q1 2025).